Critical limb ischaemia: Management and outcome. Report of a national survey  by The Vascular Surgical Society of Great Britain and Ireland, 
Eur J Vasc Endovasc Surg 10, 108-113 (1995) 
Critical Limb Ischaemia: Management and Outcome. 
Report of a National Survey 
The Vascular Surgical Society of Great Britain and Ireland 
Presented at the 8th annual meeting of the European Society for Vascular Surgery, Berlin, Germany (September 1994). 
The authors are members of the Audit Committee of the Vascular Surgical Society. 
Aim: A prospective national survey of patients with critical lower limb ischaemia was carried out to estimate the prevalence 
of critical lower limb ischaemia in Britain and Irelan& and to assess the average national outcome following treatment. 
Method: The surgeons were selected randomly but stratified according to the number of vascular surgical operations 
performed annually to match the profile of the vascular surgical population of the country as a whole. 
Outcome measures: The main outcome measures were the primary treatment intention; final treatment undertaken; 
duration of hospital stay; final outcome in terms of mortality and limb salvage rates and destination on discharge. 
Results: The data reveal that the extrapolated incidence of critical lower limb ischaemia in Great Britain and Ireland was 
21 450 limbs in 20 000 patients, equating to a prevalence of I in 2500 of the population annually. Thirty per cent of the 
patients were diabetic. The overall mortality and amputation rates were 13.5% and 21.5% respectively. The mean duration 
of hospital stay was 25 days. Nearly 70% of patients were offered some form of revascularisation as the primary treatment 
option with a 75% chance of successful limb salvage. Amputation was associated with a significantly higher mortality (Chi 
square = 10.79,p = 0.001), longer hospital stay (t = 4.589,p < 0.0001) and a greater proportion of patients requiring long- 
term institutional support, than revascularisation. The ratio of revascularisation toamputation was 4:1. Surgeons with a 
lower annual experience of patients with vascular disease tended to undertake fewer revascularisations (Chi 
square -- 6.737,p = 0.0094) and more amputations (Chi square = 10.445,p = 0.0012) than those treating larger numbers. 
The mean limb salvage rate achieved by surgeons with a lower throughput of vascular operations was significantly lower 
that achieved by other groups of surgeons (Chi square = 7.544,p = 0.0045). 
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Introduction 
During 1993, the audit committee of the Vascular 
Surgical Society of Great Britain and Ireland con- 
ducted a prospective national survey of critical limb 
ischaemia (CLI). The objectives of this study were: to 
estimate the prevalence of this condition within the 
community and the burden imposed by it upon health 
services; to determine the relative number of patients 
managed by the different treatment options available 
and to assess the average outcome in terms of 
mortalit)~ limb salvage, duration of hospital stay and 
whether the patient was returned to his own home or 
had to be permanently accommodated in an institu- 
tion. A representative sample of 100 vascular surgeons 
was randomly selected from the Society's national 
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vascular registry to contribute data to the survey. 
Confidentiality of information supplied by individual 
surgeons was carefully safeguarded but analysis of 
aggregated ata permits comparison of treatment 
policy and outcome between surgeons of differing 
specialisation and between different types of 
hospital. 
Material and Methods 
Based upon information derived from the Society's 
1992 national vascular egistry, vascular surgeons in 
the U.K. and Ireland (total number 346) were placed 
into one of four groups according to the number of 
infrainguinal reconstructions performed annually as 
follows: 0-10, group 1; 11-20, group 2; 21-30, group 3 
and more than 30, group 4. The purpose of this was to 
stratify vascular surgeons according to annual 
throughput of vascular surgical operations. Surgeons 
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were then selected randomly from each group and 
invited to participate in the study. The method for 
selecting participating surgeons and the procedure 
employed were chosen to ensure that the relative 
proportion in each of the four groups was the same as 
that for the national registry as whole. Each surgeon 
selected was asked to monitor prospectively all 
patients presenting to h im/her  with critical limb 
ischaemia during a fixed 3-month period. This period 
was chosen to promote maximum compliance by the 
participating surgeons, while ensuring an adequate 
sample size to produce reliable extrapolation of the 
data to national annual figures. For the purpose of the 
stud~ critical limb ischaemia was defined as that 
degree of ischaemia which, in the opinion of the 
surgeon, would have been likely to necessitate ampu- 
tation of the limb in the absence of successful 
revascularisation. 
Major amputation was defined as an amputation at 
thigh, lower leg level, through the knee or through the 
foot (Symes). Revascularisation included percuta- 
neous transluminal angioplasty (PTA) or lysis, and 
open reconstruction. Long-term stay included dis- 
charge to a nursing home or convalescence. 
Separate admissions and bilateral critical ischaemia 
required separate ntry forms, and data were entered 
into a database (DataEase, International Inc, 7 Cam- 
bridge Drive, Trumball, CT 06611, U.S.A.), adapted for 
the purpose. During the 3-month period of the survey 
each participating centre was telephoned at least once 
to monitor progress and as a reminder to include all 
eligible patients. 
Comparison of risk factors between patients of 
surgeons on groups 1-4 was made using the Mann- 
Whitney U-test, and comparison between discrete 
variables was made using the Chi square test. Com- 
parison between means was made using the Student's 
t-test. C.I. refers to 95% confidence interval for 
differences. 
Results 
Fifty seven of the 100 surgeons invited and agreeing to 
participate returned patient data forms (Table 1). A 
total of 736 forms were received, of which 679 
contained the necessary data for further analysis. The 
distribution of surgeons between teaching and district 
hospitals is shown in Table 1 along with the numbers 
of patients from each type of hospital. 
Table 2 shows demographic data relating to the 
patients in the four groups. The male to female ratio 
was 1.48 to 1. The distribution of men and women by 
Table 1. Details of the surgeons invited to participate, returning 
data and legs included, distributed between teaching and district 
hospitals for the tour groups of surgeons 
All Group I Group 2 Group 3 Group 4
n n n n T/ 
Invited 
Teaching 40 6 7 11 16 
District 60 25 15 13 7 
Total 100 31 22 24 23 
Returning data 
Teaching 19 2 4 4 9 
District 38 15 9 8 6 
Total 57 17 13 12 16 
Legs included 
Teaching 314 19 49 84 162 
District 365 101 107 70 87 
Total 679 120 156 154 249 
Table 2. Patient demographic data 
All Group i Group 2 Group 3 Group 4
n % n % n % n % n % 
Total 679 120 18 156 23 154 23 249 37 
Sex 
Men 406 60 71 59 86 55 85 55 164 66 
Women 273 40 49 41 70 45 69 45 85 34 
Age groups 
<60years 79 12 14 12 17 11 14 9 34 14 
60-69years 167 25 23 19 36 23 42 27 66 27 
70-79years 260 38 53 44 51 33 61 40 95 38 
80+years 173 25 30 25 52 33 37 24 54 22 
Diabetes 204 30 36 30 54 35 53 34 61 24.5 
Symptoms 
Rest pain 505 74.4 94 78.3 103 66 108 70 200 80.3 
Ulceration 215 31.7 50 41.7 41 26 49 32 75 30.1 
Gangrene 231 34 50 41.7 41 42 49 32 75 30.1 
Duration of 
symptoms 
<8days 149 21.9 27 22.5 27 17 26 17 69 27.7 
8-14days 87 12.8 13 12.8 24 11 19 15 31 12.4 
15-21days 76 11.2 6 5 19 12 23 15 28 11.2 
>21 days 368 54.2 74 61.7 86 55 86 56 122 49 
ASAgradeI 19 2.8 2 1.67 4 2.5 7 4.5 6 2.4 
II 229 33.7 39 32.5 46 30 55 36 89 35.7 
III 287 42.3 52 43.3 84 54 64 42 87 34.9 
IV 100 14.7 20 16.7 16 10 18 12 46 18.5 
V 8 1.1 1 1.2 1 0.6 0 0 6 2.4 
Not known 36 5.3 6 5 5 3.2 10 6.5 15 6 
Angiogram 542 80 97 81 132 85 129 84 184 74 
age group (Fig. 1) shows that males predominated in
the younger age groups, but in those over 80 years, the 
sex distribution was equal. The peak incidence of CLI, 
in both sexes, was in those aged 70-79. Thirty percent 
of the ischaemic legs were in diabetic patients and 
most persons were classified as ASA (American 
Society of Anaestheologists classification of patients 
according to their general condition, grade I being a 
normal healthy patient and grade V a moribund 
patient, not expected to survice 24h with, or without, 
an operation) grades II and III (Table 2). The mean 
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ankle brachial index for diabetics was 0.40 (range 
0-1.54) and for non-diabetics was 0.30 (range 0-1.70). 
The proport ion of diabetics with an ankle systolic 
pressure below 50 mmHg was 45% and for non- 
diabetics the proport ion was 42%. Seventy nine 
percent of patients were admitted f rom home, 6% 
from a nurs ing home and 12% from another hospital. 
Rest pain was the most  frequent present ing symptom 
(74%) fol lowed by  gangrene (34%) and ulceration 
(31%) (Table 2). Only  eight patients had neither rest 
pain, gangrene nor ulceration. In 54% of limbs, 
symptoms had been present for more than 21 days 
and in 21% less than 8 days. The distr ibution of 
patients by  age and sex, presence of diabetes, ASA 
grade, source of admission and symptoms was similar 
for all four groups of surgeons. 
The breakdown of legs into management  groups is 
shown in Table 3. Revascularisation was undertaken 
in 63% of l imbs whereas 16% had a pr imary  major 
amputat ion,  8% medical  or minor  treatment only and 
13% no treatment. Overa l l  l imb salvage was 68%, 
mean durat ion of hospital stay 24 days, deaths 14% 
and discharged irectly home 79%. 
Revascularisation was attempted significantly less 
often by surgeons in group 1 (53% vs.  65%, Chi 
square = 6.37, p = 0.0094, CI = 0.42-0.85). These same 
surgeons used bypass graft ing more often, (84% vs.  
65%, Chi square 12.7, p = 0.0004, CI = 1.7-8.1), than 
the surgeons in the other three groups. Overa l l  l imb 
salvage, mean hospital sta3~ secondary amputat ion,  
deaths and placement on discharge were similar for all 
four groups of surgeons. Of the 427 revascularisations, 
290 (68%) involved a bypass graft and 147 (34%) PTA 
or lysis. On 24 occasions (6%) graft ing and angioplasty 
were combined. Other revascularisation procedures 
inc luded femoral  thromboendarterectomy (n = 6), 
embolectomy (n = 14) and profundoplasty  (n = 7). 
The patency on discharge of all revascularisations was 
75% and there was no difference in death or sub- 
sequent amputat ion between the four groups of 
surgeons (Chi square = 0, p = NS, CI -- 0.26-3.31). Sur- 
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Fig. 1. The male and female distribution according to age groups, 
(11) male; ([2) female. 
Table 3. Details of numbers and outcome for the patient treatment 
groups: revascularisation primary major amputation, medical or 
minor treatment and no treatment for the four groups of surgeons 
All Group i Group 2 Group 3 Group 4 
n % n % n % n % n % 
Total 
n 679 120 156 154 249 
Limb salvage 463 68 68 57 111 71 107 69 177 71 
Days hospital 24 30 25 26 21 
Major 
amputation 146 22 39 33 32 21 34 22 41 16 
Died 92 14 17 14 18 12 20 13 37 15 
Discharged 
home 539 79 102 85 128 82 108 70 210 84 
Revascularisation 
n 427 63 63 53 95 61 105 68 164 66 
Limb salvage 363 85 53 84 80 84 89 85 141 86 
Days hospital 23 26 25 25 20 
Graft 290 68 55 87 57 60 75 71 103 63 
PTA/Lysis 147 34 14 22 41 43 32 30 60 37 
Other 56 13 5 8 16 17 12 11 23 14 
Major 
amputation 39 9 6 10 9 9 12 11 12 7 
Died 28 7 4 6 6 6 6 6 12 7 
Discharged 
home 299 70 46 73 57 60 75 71 121 74 
Primary 
amputation 
n 107 16 33 28 23 15 22 14 29 12 
Days hospital 45 49 47 43 40 
Died 19 18 4 12 5 22 5 23 5 17 
Discharged 
home 42 39 16 48 9 39 7 32 10 34 
Medical minor 
treat 
n 56 8 8 7 18 12 14 9 16 6 
Limb salvage 50 89 8 100 17 94 11 79 14 88 
Days in 
hospital 18 28 13 18 20 
Died 6 11 1 13 1 6 3 21 2 13 
Discharged 
home 43 77 6 75 15 83 8 57 14 88 
No treatment 
n 89 13 16 13 20 13 13 8 40 16 
Limb salvage 50 56 7 44 14 70 7 54 22 55 
Days 
hospital 13 12 11 18 12 
Died 39 44 9 56 6 30 6 46 18 45 
Discharged 
home 33 37 3 19 13 65 5 38 12 30 
Percentages on this table need some explanation, the row opposite n
are of total egs in the surgeons group, whereas the other percentage 
are of the number in the subgroup. 
geons in group 1 per formed significantly fewer PTAs 
than those in the other three groups (Chi 
square = 4.59, with Yates' correction p = 0.032, 
CI = 0.21-0.89). For bypass grafts, auto logous vein 
was used in 101 (34%) -polytetraf luoroethylene limbs, 
(PTFE) in 98 (33.8%) and Dacron in 52 (11.9%). A 
bypass graft was taken to the popliteal artery in 116 
(39%) legs with approximately  equal numbers  to the 
above-knee (n = 55, 19%) and below-knee (n = 65, 
23%) segments. Sixty nine bypasses (25%) were to the 
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crural vessels and three (1%) to the foot. Approx- 
imately equal numbers of above- and below-knee 
bypasses were performed by all groups. PTA was 
most frequently undertaken on the superficial artery 
(n = 72, 58.5%), other sites were common iliac artery 
(n = 16, 13%) and previous graft (n = 16, 13%). 
The surgeons in group 1 performed a significantly 
greater number of primary amputations than those in 
groups 2, 3, and 4 (28% vs.  13%, Chi square 12.2, 
p = 0.0005, CI = 1.46-4.40). These primary amputees 
occupied a hospital bed for a mean of 45 days 
compared to 23 days for those having revascularisa- 
tion (Student's t-test t = 4.60, p<0.0001, CI =-  
17.1--6.8) and a significantly greater number of 
patients died following amputation than after revas- 
cularisation (18% vs.  7% Chi square = 10.79, p = 0.001, 
C.I. = 1.48-5.34). 
Medical therapy or minimal surgery was the man- 
agement in 56 limbs, with a mortality of 10.7%, limb 
salvage rate of 89%, deaths of 11% and 39% were 
discharged home. A further 89 limbs had no active 
treatment for whom the mortality rate was 44% and of 
the survivors, 37% were discharged home. 
Diabetic patients were offered primary reconstruc- 
tion less often (55% vs .  63%, Chi square = 8.03, 
p = 0.004, C.I. = 0.42-0.85) and primary amputation 
more often (23% vs .  17%, Chi square = 9.95, 
p = 0.0016, C.I. -- 1.36-3.37) than non-diabetic patients 
(60% vs.  68%, Chi square = 9.45, p = 0.0021, 
C.I. = 0.41-0.82). 
Further examination of data relating to the 146 legs 
that had a major amputation (Table 3) revealed that in 
total these legs had 161 major amputation procedures 
due to a number of legs needing re-amputation. There 
were 73 above knee, 71 below knee, 11 through knee, 
four Symes, two hip disarticulations and one unspeci- 
fied major amputation. 
Table 4. Projection of national workload relating to critical limb 
ischaemia 
National projection ofannual workload 
Number patients 20000 
Number legs 21540 
Deaths 2760 
Revascularisations 12810 
Primary amputation 3210 
Total amputation 4860 
Revascularisation : primary amputation ratio 4 : 1 
Extrapolating from these data (Table 4) the esti- 
mated incidence of CLI in the U.K. and Ireland in 1993 
was 21 450 limbs corresponding to approximately 
20 000 patients. This equates to a prevalence of 1 in 
2500 of the population each year. 
Discussion 
This study has provided the best estimate to date of 
the prevalence of limb-threatening ischaemia in Brit- 
ain and Ireland. All patients had either prolonged rest 
pain or necrosis and therefore had ischaemia compara- 
ble with Fontaine stages III and IV. Analysis of the 
preoperative ankle pressures showed that most 
patients also satisfied the criteria as defined by the 
Second European consensus for critical limb 
ischaemia. ~ 
There was no independent validation of original 
data, but it is safe to assume that participating 
surgeons were much more likely to under-report 
rather than over-report the number of patients pre- 
senting to them. Of those who did not respond, a 
number had retired or were no longer involved in 
vascular surgery. There is no way of knowing whether 
the surgical practice of the non-responders was similar 
to the responders, and this lack of information does 
slightly weaken the reliability of the extrapolated data. 
In extrapolating national statistics from those data, 
account was taken of the 10% of vascular surgical 
operations which, according to the Vascular Surgical 
Society's 1992 national registr34 is undertaken by 
surgeons who are not members of the Society. It is not 
known how many patients with critical ischaemia 
present o non-surgical specialists, but it is likely that 
the number is small. Even allowing for sampling error, 
the results confirm the perception held by many 
vascular surgeons that the total national workload 
relating to critical limb ischaemia is extremely high. 
With a prevalence of 1 in 2500 of the population and 
an incidence of 21 450 ischaemic limbs in 20 000 
patients per year the pressure imposed by this 
condition upon National Health Service resources is 
enormous and because the peak incidence occurs in 
people aged 70-79 years it must be anticipated that 
this burden will grow progressively as the number 
surviving to old age increases. In 1992, a total of 22405 
peripheral arterial reconstructions were recorded on 
the Vascular Surgical Society's registr~ equating to 47 
per 100 000 of the population. This is a rather lower 
figure than that registered in a similar population in 
Southern Scandinavia 2 but, even allowing for the 
possibility that the total vascular work load may have 
been underestimated, comparison with data from the 
present study indicates that operations for CLI 
account for at least 50% of reconstructive vascular 
procedures. The cost of a major amputation i the U.K. 
has been estimated to be more than £25000. Thus, if 
amputation should be the outcome in all patients 
presenting with CLI the annual total cost to the 
country would currently be in the order of £536M. 
Eur J Vasc Endovasc Surg Vol 10, July 1995 
112 The Vascular Surgical Society of Great Britain and Ireland 
Fortunately, the results of this study show that with 
appropriate treatment, pain free limbs are salvaged in 
the majority with relief of suffering and avoidance of 
long-term major disability. The cost to the country of 
reconstruction at an estimated average of £8.800 
including revisional surgery when required, is also 
considerably less than the cost associated with 
amputation. 3 
Although, for some time, the amputation rate in 
Britain and similar countries continued to rise despite 
an increasing number of vascular operations, evidence 
is now accumulating that as vascular surgery becomes 
more available and more effective, it is beginning to 
have a significant impact. 4'5 The present study indi- 
cated that across the country as a whole, almost 70% of 
patients were offered some form of revascularisation 
with an overall success rate of 75%. This average 
national figure compares well with previously pub- 
lished results from centres of excellence 6'7 and indi- 
cates that the standard of treatment across the country 
as a whole is high. 
The limb salvage rate for diabetics was significantly 
lower than that in non-diabetic patients. This differ- 
ence was accounted for by a lower primary recon- 
struction and a reciprocal higher primary amputation 
rate. There are reports of excellent results obtained 
from bypasses crossing the ankle in patients with a 
typical distal distribution of occlusive disease found in 
diabetics, '9 In the present survey, only three patients 
were reported with this type of bypass. If others are 
able to achieve results comparable to those published, 
there may be potential for further improvement in 
limb salvage rates in diabetics from wider application 
of these techniques. The ratio of revascularisation 
procedures to primary amputations was 4 to 1. 
Revascularisation was associated with a signifi- 
cantly lower mortality rate, shorter duration of hospi- 
tal stay and a lower proportion of patients requiring 
long-term institutional support than amputation. In 
this respect he results were similar to those reported 
from single centres} ° While it is accepted that patients 
allocated to the different reatment options were by no 
means comparable, it would seem reasonable to 
conclude from these figures that revascularisation is 
the preferred treatment option whenever technically 
feasible. In this respect the study identified some 
important differences in practice between certain 
groups of surgeons which had a significant influence 
on outcome. Those with a lower annual experience of 
vascular operations tended to undertake proportion- 
ately fewer revascularisations and more primary 
amputations than their colleagues who treat larger 
numbers of patients (Fig. 2). As a result they achieved 
a lower overall limb salvage rate. Their results 
obtained from revascularisation were comparable to 
those of surgeons with a larger vascular workload but 
they were more selective in choosing this option. In 
particular, their patients were offered endovascular 
therapies ignificantly less often and this is perhaps a 
reflection of limited availability of the necessary 
facilities and expertise in the radiology departments of
smaller hospitals. These findings may be interpreted 
as evidence that a patient with CLI is likely to have the 
best chance of limb salvage if treated in a large, well 
equipped, multidisciplinary vascular unit. Patients 
who were offered minimal surgery or were treated 
non-surgically either did not have a truly critical 
degree of ischaemia or conversely were too ill to 
permit any form of intervention. The hospital mortal- 
ity in the latter group exceeded 43% and although 
precise information was not available from the study it 
is likely that others were discharged, on strong 
analgesia, to die at home or in a nursing home. For 
some, CLI is a terminal event and in this circumstance 
surgical intervention can be unjustifiably meddle- 
some. These patients, however, constitute a small 
minority of the total number. 
The outcome measures realised by this study could 
have value as an objective basis for the formulation of 
practice guidelines relating to the management of CLI. 
There are also important implications with regards to 
future provision of healthcare resources. The high 
prevalence of CLI in countries like Britain places an 
enormous burden upon health services, but with 
appropriate application of modern vascular surgical 
and radiological techniques, uccessful limb salvage is 
possible in the majority of patients at much lower cost 
than that associated with amputation. The benefits, 
not only to the patients themselves but also to the 
community as a whole, in comparison to amputation 
make it very worthwhile investing sufficient resources 
in vascular surgical services to ensure that the demand 
for revascularisation can be met. There are indications 
that, in the future, it may be clinically and financially 
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Fig. 2. Comparison fthe number of revascularisations a dprimary 
amputations according tovascular workload of surgeons. The ratio 
of revascularisation: primary amputation for groups 1 to 4 was 3.0, 
6.9, 6.7, 7.6, respectively. (v1) revascularisation; (W) amputation. 
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advantageous to concentrate hose available resources 
in fewer more specialised vascular units. 
Brown, of the Department of Statistics and Medical Computing at 
the University of Liverpool. 
Conclusions 
The following are the main points arising from this 
study. 
(1) With an incidence of 20000 patients and a preva- 
lence of 1 in 2500 of the population annually CLI 
represents a major burden on hospital services in 
Britain and Ireland. This burden is likely to increase 
progressively as the number of people surviving into 
old age increases because the peak incidence of the 
condition occurs in those aged 70-79 years. 
(2) Thirty percent of the patients were diabetic. 
(3) The mean mortality and amputation rate for all 
patients in the survey were 13.5% and 21.5% respec- 
tively. The mean duration of hospital stay was 25 days 
and 26.1% required long-term institutional support. 
(4) Nearly 70% of patients were offered some form of 
revascularisation as the primary treatment option 
with a 75% chance of successful limb salvage. 
(5) Amputation was associated with significantly 
higher mortality, longer hospital stay and a larger 
proportion of patients requiring long-term institu- 
tional support. 
(6) Patients with CLI were just as likely to be treated in 
district general hospitals as in teaching hospitals, but 
individual surgeons in teaching hospitals tended to 
see more patients with this condition annually. 
(7) Surgeons with a low throughput of patients with 
vascular disease tended to undertake fewer revascu- 
larisations and more primary amputations than those 
treating larger numbers. In particular, patients of these 
surgeons were relatively unlikely to be offered trans- 
luminal angioplasty, though the rate of infrapopliteal 
bypass was equally distributed amongst the four 
groups of surgeons. 
(8) The mean limb salvage rate achieved by surgeons 
with a low annual experience of vascular operations 
was significantly lower than that achieved by the 
other groups of surgeons. There were no significant 
differences in mortality rates for patients treated by 
the different groups of surgeons included in the 
survey. 
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